机构:[1]Department of Clinical Laboratory, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China深圳市康宁医院深圳医学信息中心[2]Department of Clinical Laboratory, The First Affiliated Hospital, University of South China, Hengyang, Hunan, China[3]Department of Clinical Laboratory, The Second Affiliated Hospital, Hainan Medical University, Haikou, Hainan, China[4]Department of Hematology, The First Affiliated Hospital, University of South China, Hengyang, Hunan, China[5]Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China
National Natural Science Foundation of China (Nos.
81870105 and 81770107), the Scientific Research Fund Project of Hunan Provincial Health
Commission (No. 20201921), and the Scientific Research and Innovation Project of
postgraduates in Hunan Province (No. CX20200970).
第一作者机构:[1]Department of Clinical Laboratory, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China[2]Department of Clinical Laboratory, The First Affiliated Hospital, University of South China, Hengyang, Hunan, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Clinical Laboratory, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China[2]Department of Clinical Laboratory, The First Affiliated Hospital, University of South China, Hengyang, Hunan, China
推荐引用方式(GB/T 7714):
Liu Zhaoping,Wang Yanyan,Xu Zhenru,et al.Analysis of ceRNA networks and identification of potential drug targets for drug-resistant leukemia cell K562/ADR.[J].PEERJ.2021,9:doi:10.7717/peerj.11429.
APA:
Liu Zhaoping,Wang Yanyan,Xu Zhenru,Yuan Shunling,Ou Yanglin...&Zhang Ji.(2021).Analysis of ceRNA networks and identification of potential drug targets for drug-resistant leukemia cell K562/ADR..PEERJ,9,
MLA:
Liu Zhaoping,et al."Analysis of ceRNA networks and identification of potential drug targets for drug-resistant leukemia cell K562/ADR.".PEERJ 9.(2021)